Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Classical hematology 1

Conditions

Neoplasms 2Melanoma 2Carcinoma, Hepatocellular 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms by Site 1Neoplasms by Histologic Type 1Myelodysplastic Syndromes 1Hematologic Neoplasms 1Cytopenia 1Coronavirus Infections 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1

Interventions

AP 1903 reagent 3ON 01910 2Biopsy 2thymoglobulin 1fludarabine phosphate 1fludarabine 1epacadostat 1decitabine and cedazuridine drug combination 1cedazuridine 1angiotensin I (1-7) 1Vitamin B 12 1Specimen Handling 1Sertraline 1Pluvicto 1Peripheral Blood Stem Cell Transplantation 1Metformin 1Interleukin-8 1IDO-1 inhibitor LY3381916 1HuMax-IL8 1Granulocyte Colony-Stimulating Factor 1Genetic Counseling 1Folic Acid 1Filgrastim 1Exercise 1Emapalumab 1Decitabine 1DNA 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cytopenia × HuMax-IL8 × Clear all
NCT05148234 2025-09-30

BMS-986253 in Myelodysplastic Syndromes

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
2 enrolled 11 charts
Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡